The local peripheral antihyperalgesic effect of levetiracetam and its mechanism of action in an inflammatory pain model

Anesthesia and Analgesia

Volumn 115, Issue 6, 2012, Pages 1457-1466

  Stepanović Petrović, Radica M ^a   Micov, Ana M ^a   Tomić, Maja A ^a   Ugrešić, Nenad D ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

1,3,4,5',6,6',7,12B OCTAHYDRO 1',3' DIMETHYL 2H SPIRO[BENZO[B]FURO[2,3 A]QUINOLIZINE 2,4' PYRIMIDINE] 2' ONE; 2 (1 METHYL 2 ISOINDOLINYLMETHYL) 2 IMIDAZOLINE; 4 AMINOBUTYRIC ACID RECEPTOR; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADRENERGIC RECEPTOR; BICUCULLINE; CAFFEINE; CARRAGEENAN; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLARGINYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; ETIRACETAM; METHYSERGIDE; N [4 METHOXY 3 (4 METHYL 1 PIPERAZINYL)PHENYL] 2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL)[1,1' BIPHENYL] 4 CARBOXAMIDE; NALOXONE; OPIATE RECEPTOR; PURINERGIC RECEPTOR; SEROTONIN RECEPTOR; YOHIMBINE;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; HYPERALGESIA; INFLAMMATORY PAIN; MALE; NONHUMAN; PAW EDEMA; PLETHYSMOGRAPHY; PRIORITY JOURNAL; RAT;

ADENOSINE A1 RECEPTOR ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANESTHETICS, LOCAL; ANIMALS; CARRAGEENAN; DRUG INTERACTIONS; EDEMA; FOOT; GABA ANTAGONISTS; HINDLIMB; HYPERALGESIA; INFLAMMATION; MALE; PAIN; PERIPHERAL NERVES; PIRACETAM; PLETHYSMOGRAPHY; RATS; RATS, WISTAR; RECEPTORS, OPIOID; SEROTONIN ANTAGONISTS;

EID: 84870243260     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ANE.0b013e31826c7fc2     Document Type: Article

References (43)

1. Ardid D, Lamberty Y, Alloui A, Coudore-Civiale MA, Klitgaard H, Eschalier A. Antihyperalgesic effect of levetiracetam in neuropathic pain models in rats. Eur J Pharmacol 2003;473:27-33
2. Archer DP, Lamberty Y, Wang B, Davis MJ, Samanani N, Roth SH. Levetiracetam reduces anesthetic-induced hyperalgesia in rats. Anesth Analg 2007;104:180-5
3. Silva J, Dolezal T, Prochazkova M, Votava M, Krsiak M. Preemptive levetiracetam decreases postoperative pain in rats. Neuro Endocrinol Lett 2008;29:953-7
4. Micov A, Tomíc M, Popovíc B, Stepanovíc- Petrovíc R. The antihyperalgesic effect of levetiracetam in an infammatory model of pain in rats: mechanism of action. Br J Pharmacol 2010;161:384-92
5. Jorns TP, Johnston A, Zakrzewska JM. Pilot study to evaluate the effcacy and tolerability of levetiracetam (Keppra) in treatment of patients with trigeminal neuralgia. Eur J Neurol 2009;16:740-4
6. Pascual-Gómez J. The role of the neuromodulators in the preventive treatment of migraine. Rev Neurol 2009;49:25-32
7. Rossi S, Mataluni G, Codecà C, Fiore S, Buttari F, Musella A, Castelli M, Bernardi G, Centonze D. Effects of levetirace-tam on chronic pain in multiple sclerosis: results of a pilot, randomized, placebo-controlled study. Eur J Neurol 2009; 16:360-6
8. Falah M, Madsen C, Holbech JV, Sindrup SH. A randomized, placebo-controlled trial of levetiracetam in central pain in multiple sclerosis. Eur J Pain 2012;16:860-9
9. Sawynok J. Topical and peripherally acting analgesics. Pharmacol Rev 2003;55:1-20
10. Morris CJ. Carrageenan-induced paw edema in the rat and mouse. In: Winyard PG, Willoughby DA, eds. Infammation Protocols (Methods in Molecular Biology). Vol 225. Totowa, NJ: Humana Press Inc., 2003:115-23
11. Randall LO, Selitto JJ. A method for measurement of analgesic activity on infamed tissue. Arch Int Pharmacodyn Ther 1957;111:409-19
12. Tomíc MA, Vučković SM, Stepanovíc- Petrovíc RM, Ugrešić N, Prostran MS, Bošković B. The anti-hyperalgesic effects of carba-mazepine and oxcarbazepine are attenuated by treatment with adenosine receptor antagonists. Pain 2004;111:253-60
13. Bianchi M, Rossoni G, Sacerdote P, Panerai AE, Berti F. Carbamazepine exerts anti-infammatory effects in the rat. Eur J Pharmacol 1995;294:71-4
14. Tallarida RJ, Murray RB. Manual of Pharmacologic Calculations with Computer Programs. 2nd ed. New York: Springer-Verlag, 1986
15. Tallarida RJ. Drug Synergism and Dose-Effect Data Analysis. 1st ed. Boca Raton, FL: Chapman & Hall/CRC, 2000
16. Todorovíc SM, Rastogi AJ, Jevtovíc-Todorovíc V. Potent analgesic effects of anticonvulsants on peripheral thermal nociception in rats. Br J Pharmacol 2003;140:255-60
17. Tomíc MA, Vučković SM, Stepanovíc- Petrovíc RM, Ugrešić N, Prostran MS, Bošković B. Peripheral anti-hyperalgesia by oxcar-bazepine: involvement of adenosine A1 receptors. Pharmazie 2006;61:566-8
18. Vučković S, Tomíc M, Stepanovíc- Petrovíc R, Ugrešić N, Prostran M, Boškovíc B. Peripheral antinociception by carba-mazepine in an infammatory mechanical hyperalgesia model in the rat: a new target for carbamazepine? J Pharmacol Sci 2006;100:310-4
19. Paranos SL, Tomíc MA, Micov AM, Stepanović-Petrovíc RM. The mechanisms of antihyperalgesic effect of topiramate in a rat model of infammatory hyperalgesia. Fundam Clin Pharmacol 2011 Dec 5. doi:10.1111/j.1472- 8206.2011.01018.x. [Epub ahead of print]
20. Machelska H, Cabot PJ, Mousa SA, Zhang Q, Stein C. Pain control in infammation governed by selectins. Nat Med 1998;4:1425-8
21. Machelska H, Mousa SA, Brack A, Schopohl JK, Rittner HL, Schafer M, Stein C. Opioid control of infammatory pain regulated by intercellular adhesion molecule-1. J Neurosci 2002;22:5588-96
22. 2+ current in pyramidal neurones of rat hippocampal slices. Neurosci Lett 2001; 306:5-8
23. Lukyanetz EA, Shkryl VM, Kostyuk PG. Selective blockade of N-type calcium channels by levetiracetam. Epilepsia 2002;43:9-18
24. Wu ZZ, Chen SR, Pan HL. Differential sensitivity of N-and P/Q-type Ca2+ channel currents to a mu opioid in isolec-tin B4-positive and-negative dorsal root ganglion neurons. J Pharmacol Exp Ther 2004;311:939-47
25. Scroggs RS, Fox A P. Calcium current variation between acutely isolated adult rat dorsal root ganglion neurons of different size. J Physiol 1992;445:639-58
26. Xie YK, Xiao WH, Li HQ. The relationship between new ion channels and ectopic discharges from a region of nerve injury. Sci China B 1993;36:68-74
27. White DM, Cousins MJ. Effect of subcutaneous administration of calcium channel blockers on nerve injury-induced hyperal-gesia. Brain Res 1998;801:50-8
28. Millan MJ. Descending control of pain. Prog Neurobiol 2002;66:355-474
29. Vučković SM, Tomíc MA, Stepanovíc- Petrovíc RM, Ugrešić N, Prostran MS, Bošković B. The effects of alpha2-adreno-ceptor agents on anti-hyperalgesic effects of carbamazepine and oxcarbazepine in a rat model of infammatory pain. Pain 2006;125:10-9
30. Khasar SG, Green PG, Chou B, Levine JD. Peripheral nocicep-tive effects of alpha 2-adrenergic receptor agonists in the rat. Neuroscience 1995;66:427-32
31. Jänig W, Levine JD, Michaelis M. Interactions of sympathetic and primary afferent neurons following nerve injury and tissue trauma. Prog Brain Res 1996;113:161-84
32. Aley KO, Levine JD. Multiple receptors involved in peripheral alpha 2, mu, and A1 antinociception, tolerance, and withdrawal. J Neurosci 1997;17:735-44
33. Tomíc MA, Vučković SM, Stepanovíc- Petrovíc RM, Ugrešić ND, Paranos SLj, Prostran MS, Boškovíc B. The involvement of peripheral alpha 2-adrenoceptors in the antihyperalgesic effect of oxcarbazepine in a rat model of infammatory pain. Anesth Analg 2007;105:1474-81
34. Schulte G, Robertson B, Fredholm BB, DeLander GE, Shortland P, Molander C. Distribution of antinociceptive adenosine A1 receptors in the spinal cord dorsal horn, and relationship to primary afferents and neuronal subpopulations. Neuroscience 2003;121:907-16
35. Aley KO, Green PG, Levine JD. Opioid and adenosine peripheral antinociception are subject to tolerance and withdrawal. J Neurosci 1995;15:8031-8
36. Liu XJ, Sawynok J. Peripheral antihyperalgesic effects by adenosine A1 receptor agonists and inhibitors of adenos-ine metabolism in a rat neuropathic pain model. Analgesia 2000;5:19-29
37. Sawynok J, Liu XJ. Adenosine in the spinal cord and periphery: release and regulation of pain. Prog Neurobiol 2003;69:313-40
38. Bingham S, Davey PT, Sammons M, Raval P, Overend P, Parsons AA. Inhibition of infammation-induced thermal hypersen-sitivity by sumatriptan through activation of 5-HT (1B/1D) receptors. Exp Neurol 2001;167:65-73
39. Granados-Soto V, Argüelles CF, Rocha-González HI, Godí-nez-Chaparro B, Flores-Murrieta FJ, Villalón CM. The role of peripheral 5-HT1A, 5-HT1B, 5-HT1D, 5-HT1E and 5-HT1F serotonergic receptors in the reduction of nociception in rats. Neuroscience 2010;165:561-8
40. Buzzi MG, Carter WB, Shimizu T, Heath H 3rd, Moskowitz MA. Dihydroergotamine and sumatriptan attenuate levels of CGRP in plasma in rat superior sagittal sinus during electrical stimulation of the trigeminal ganglion. Neuropharmacology 1991;30:1193-200
41. Sawynok J. GABAergic mechanisms of analgesia: an update. Pharmacol Biochem Behav 1987;26:463-74
42. Carlton SM, Zhou S, Coggeshall RE. Peripheral GABA(A) receptors: evidence for peripheral primary afferent depolarization. Neuroscience 1999;93:713-22
43. Stepanovíc-Petrovíc RM, Tomíc MA, Vučković SM, Kocev N, Ugrešić ND, Prostran MS, Bošković B. GABAergic mechanisms are involved in the antihyperalgesic effects of carbamazepine and oxcarbazepine in a rat model of infammatory hyperalge-sia. Pharmacology 2008;82:53-8